During the past decade, Northwestern Medical Faculty Foundation conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 27 clinical trials were completed, i.e. on average, 168.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwestern Medical Faculty Foundation" #1 sponsor was "Northwestern University" with 22 trials, followed by "Pfizer" with 8 trials sponsored, "Jaeb Center for Health Research" with 6 trials sponsored, "Amgen" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwestern Medical Faculty Foundation" #1 collaborator was "National Eye Institute (NEI)" with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Northwestern Medical Faculty Foundation" are "Diabetic Macular Edema" (5 trials), "Acute Myeloid Leukemia" (3 trials), "Colorectal Cancer" (3 trials), "Breast Cancer" (2 trials) and "Chronic Prostatitis With Chronic Pelvic Pain Syndrome" (2 trials). Many other conditions were trialed in "Northwestern Medical Faculty Foundation" in a lesser frequency.

Most popular intervention types in "Northwestern Medical Faculty Foundation" are "Drug" (41 trials), "Biological" (5 trials), "Procedure" (5 trials), "Behavioral" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Enzalutamide" (3 trials), "Apremilast" (2 trials), "Deferred aflibercept" (2 trials) and "Deferred laser" (2 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern Medical Faculty Foundation" are 52 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Northwestern Medical Faculty Foundation". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Northwestern Medical Faculty Foundation, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern Medical Faculty Foundation, 7 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".